Department of Internal and Integrative Medicine, Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen, Essen, Germany.
J Psychosom Res. 2013 Dec;75(6):500-10. doi: 10.1016/j.jpsychores.2013.10.010. Epub 2013 Oct 26.
This paper presents a systematic review and meta-analysis of the effectiveness of mindfulness-based stress reduction (MBSR) for FMS.
The PubMed/MEDLINE, Cochrane Library, EMBASE, PsychINFO and CAMBASE databases were screened in September 2013 to identify randomized and non-randomized controlled trials comparing MBSR to control interventions. Major outcome measures were quality of life and pain; secondary outcomes included sleep quality, fatigue, depression and safety. Standardized mean differences and 95% confidence intervals were calculated.
Six trials were located with a total of 674 FMS patients. Analyses revealed low quality evidence for short-term improvement of quality of life (SMD=-0.35; 95% CI -0.57 to -0.12; P=0.002) and pain (SMD=-0.23; 95% CI -0.46 to -0.01; P=0.04) after MBSR, when compared to usual care; and for short-term improvement of quality of life (SMD=-0.32; 95% CI -0.59 to -0.04; P=0.02) and pain (SMD=-0.44; 95% CI -0.73 to -0.16; P=0.002) after MBSR, when compared to active control interventions. Effects were not robust against bias. No evidence was further found for secondary outcomes or long-term effects of MBSR. Safety data were not reported in any trial.
This systematic review found that MBSR might be a useful approach for FMS patients. According to the quality of evidence only a weak recommendation for MBSR can be made at this point. Further high quality RCTs are required for a conclusive judgment of its effects.
本文对正念减压疗法(MBSR)治疗纤维肌痛综合征(FMS)的疗效进行了系统评价和荟萃分析。
2013 年 9 月,我们对 PubMed/MEDLINE、Cochrane 图书馆、EMBASE、PsycINFO 和 CAMBASE 数据库进行了筛选,以确定比较 MBSR 与对照干预措施的随机和非随机对照试验。主要结局指标为生活质量和疼痛;次要结局指标包括睡眠质量、疲劳、抑郁和安全性。计算了标准化均数差和 95%置信区间。
共发现 6 项试验,共有 674 例 FMS 患者。分析结果显示,与常规护理相比,MBSR 可在短期改善生活质量(SMD=-0.35;95%CI -0.57 至 -0.12;P=0.002)和疼痛(SMD=-0.23;95%CI -0.46 至 -0.01;P=0.04),但证据质量较低;与活性对照干预相比,MBSR 也可在短期改善生活质量(SMD=-0.32;95%CI -0.59 至 -0.04;P=0.02)和疼痛(SMD=-0.44;95%CI -0.73 至 -0.16;P=0.002),但证据质量同样较低。结果不能抵抗偏倚的影响。没有进一步的证据表明 MBSR 的次要结局或长期效果。任何试验均未报告安全性数据。
本系统评价发现,MBSR 可能是治疗 FMS 患者的一种有用方法。根据证据质量,目前只能对 MBSR 提出微弱推荐。需要进一步进行高质量 RCT 以确定其确切疗效。